Barbara Konkle

Professor of Medicine

University of Washington

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Barbara Konkle is a Professor of Medicine at the University of Washington in the United States. Her research focuses on gene therapy for haemophilia, bleeding disorder registries, and the clinical management of bleeding disorders. Recent articles highlight her work in assessing gene therapy efficacy, immune responses related to AAV, and the psychological impacts of bleeding disorders. Professor Konkle is dedicated to advancing clinical practice and improving patient outcomes in the field of hematology.

Articles (17)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

View details

Huyen Tran

Director, Haemophilia Treatment Centre and Head, Haemostasis Thrombosis Unit

Alfred Health

AUSTRALIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Barbara Konkle

Research Interests

Explore related searches

Contact this professor

About

Articles (17)

The Critical Need to Consolidate All Gene Therapy Data in Haemophilia

Corticosteroid use to mitigate transaminitis-associated decline in FVIII levels following valoctocogene roxaparvovec gene therapy: clinical practice guidance

Multicenter assessment and longitudinal study of the prevalence of antibodies and related adaptive immune responses to AAV in adult males with hemophilia

The importance and evolution of bleeding disorder registries

Giroctocogene fitelparvovec gene therapy for severe hemophilia A: 104-week analysis of the phase 1/2 Alta study

A global comparative field study to evaluate the factor VIII activity of efanesoctocog alfa by one‐stage clotting and chromogenic substrate assays at clinical haemostasis laboratories

Landmark endorsement of a global registry: The European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP), publicly endorses World Federation of Hemophilia Gene Therapy Registry as global standard

Depression and anxiety in persons with Von Willebrand disease

How I approach bleeding in hospitalized patients

Efanesoctocog alfa for the prevention and treatment of bleeding in patients with hemophilia A

Comorbidities, Health-Related Quality of Life, Health-care Utilization in Older Persons with Hemophilia—Hematology Utilization Group Study Part VII (HUGS VII)

Achieving access to haemophilia care in low-income and lower-middle-income countries: expanded Humanitarian Aid Program of the World Federation of Hemophilia after 5 years

The burden of heavy menstrual bleeding

Phenotypic analysis of erythrocytes in sickle cell disease using imaging flow cytometry

A Prospective Observational Study of Antihemophilic Factor (Recombinant) Prophylaxis Related to Physical Activity Levels in Patients with Hemophilia A in the United States (SPACE)

ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease

ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease

Collaborators (9)

Roshni Kulkarni

Michael Nichol

AMY DUNN

Mark Skinner

Miguel Escobar

Barbara Ameer

Jonathan C. Roberts

Peter Kouides

Huyen Tran

Make your next move.